IBDEI1JZ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26341,1,4,0)
 ;;=4^F18.159
 ;;^UTILITY(U,$J,358.3,26341,2)
 ;;=^5003387
 ;;^UTILITY(U,$J,358.3,26342,0)
 ;;=F18.259^^98^1245^12
 ;;^UTILITY(U,$J,358.3,26342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26342,1,3,0)
 ;;=3^Inhalant Induced Psychotic Disorder w/ Mod/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,26342,1,4,0)
 ;;=4^F18.259
 ;;^UTILITY(U,$J,358.3,26342,2)
 ;;=^5003400
 ;;^UTILITY(U,$J,358.3,26343,0)
 ;;=F18.959^^98^1245^13
 ;;^UTILITY(U,$J,358.3,26343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26343,1,3,0)
 ;;=3^Inhalant Induced Psychotic Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,26343,1,4,0)
 ;;=4^F18.959
 ;;^UTILITY(U,$J,358.3,26343,2)
 ;;=^5003412
 ;;^UTILITY(U,$J,358.3,26344,0)
 ;;=F18.99^^98^1245^20
 ;;^UTILITY(U,$J,358.3,26344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26344,1,3,0)
 ;;=3^Inhalant Related Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,26344,1,4,0)
 ;;=4^F18.99
 ;;^UTILITY(U,$J,358.3,26344,2)
 ;;=^5133360
 ;;^UTILITY(U,$J,358.3,26345,0)
 ;;=F70.^^98^1246^1
 ;;^UTILITY(U,$J,358.3,26345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26345,1,3,0)
 ;;=3^Intellectual Disabilities,Mild
 ;;^UTILITY(U,$J,358.3,26345,1,4,0)
 ;;=4^F70.
 ;;^UTILITY(U,$J,358.3,26345,2)
 ;;=^5003668
 ;;^UTILITY(U,$J,358.3,26346,0)
 ;;=F71.^^98^1246^2
 ;;^UTILITY(U,$J,358.3,26346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26346,1,3,0)
 ;;=3^Intellectual Disabilities,Moderate
 ;;^UTILITY(U,$J,358.3,26346,1,4,0)
 ;;=4^F71.
 ;;^UTILITY(U,$J,358.3,26346,2)
 ;;=^5003669
 ;;^UTILITY(U,$J,358.3,26347,0)
 ;;=F72.^^98^1246^3
 ;;^UTILITY(U,$J,358.3,26347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26347,1,3,0)
 ;;=3^Intellectual Disabilities,Severe
 ;;^UTILITY(U,$J,358.3,26347,1,4,0)
 ;;=4^F72.
 ;;^UTILITY(U,$J,358.3,26347,2)
 ;;=^5003670
 ;;^UTILITY(U,$J,358.3,26348,0)
 ;;=F73.^^98^1246^4
 ;;^UTILITY(U,$J,358.3,26348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26348,1,3,0)
 ;;=3^Intellectual Disabilities,Profound
 ;;^UTILITY(U,$J,358.3,26348,1,4,0)
 ;;=4^F73.
 ;;^UTILITY(U,$J,358.3,26348,2)
 ;;=^5003671
 ;;^UTILITY(U,$J,358.3,26349,0)
 ;;=F78.^^98^1246^5
 ;;^UTILITY(U,$J,358.3,26349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26349,1,3,0)
 ;;=3^Intellectual Disabilities,Oth Specified
 ;;^UTILITY(U,$J,358.3,26349,1,4,0)
 ;;=4^F78.
 ;;^UTILITY(U,$J,358.3,26349,2)
 ;;=^5003672
 ;;^UTILITY(U,$J,358.3,26350,0)
 ;;=F79.^^98^1246^6
 ;;^UTILITY(U,$J,358.3,26350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26350,1,3,0)
 ;;=3^Intellectual Disabilities,Unspec
 ;;^UTILITY(U,$J,358.3,26350,1,4,0)
 ;;=4^F79.
 ;;^UTILITY(U,$J,358.3,26350,2)
 ;;=^5003673
 ;;^UTILITY(U,$J,358.3,26351,0)
 ;;=Z00.6^^98^1247^1
 ;;^UTILITY(U,$J,358.3,26351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26351,1,3,0)
 ;;=3^Exam of Participant of Control in Clinical Research Program
 ;;^UTILITY(U,$J,358.3,26351,1,4,0)
 ;;=4^Z00.6
 ;;^UTILITY(U,$J,358.3,26351,2)
 ;;=^5062608
 ;;^UTILITY(U,$J,358.3,26352,0)
 ;;=F45.22^^98^1248^1
 ;;^UTILITY(U,$J,358.3,26352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26352,1,3,0)
 ;;=3^Body Dysmorphic Disorder
 ;;^UTILITY(U,$J,358.3,26352,1,4,0)
 ;;=4^F45.22
 ;;^UTILITY(U,$J,358.3,26352,2)
 ;;=^5003588
 ;;^UTILITY(U,$J,358.3,26353,0)
 ;;=F45.20^^98^1248^7
 ;;^UTILITY(U,$J,358.3,26353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26353,1,3,0)
 ;;=3^Hypochondiacal Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,26353,1,4,0)
 ;;=4^F45.20
 ;;^UTILITY(U,$J,358.3,26353,2)
 ;;=^5003586
 ;;^UTILITY(U,$J,358.3,26354,0)
 ;;=F45.21^^98^1248^9
 ;;^UTILITY(U,$J,358.3,26354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26354,1,3,0)
 ;;=3^Hypochondriasis
